FibroGen

USA

FibroGen Inc

409 Illinois St.

Thomas B. Neff, Chairman, Founder, Chief Executive Officer
Pat Cotroneo, Vice President, Finance, and Chief Financial Officer
David M. Dimmick, Vice President, Quality
R. Wayne Frost, PharmD, Vice President, Regulatory Affairs
Al Lin, MD, PhD, Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)
Michael D. Lowenstein, Vice President, Legal Affairs
Michael Martinelli, PhD, Vice President, Technical Development
James W. Polarek, PhD, Vice President, Protein Therapeutics and Collagen Development
Leanne C. Price, Vice President, Intellectual Property and Corporate Strategy
Ted Tucker, Vice President, Human Resources
Frank H. Valone, MD, Chief Medical Officer
K. Peony Yu, MD, Vice President, Clinical Development

Oncology

Production

Blood cancer

Thomas B. Neff, Chairman, Founder, Chief Executive Officer
Thomas F. Kearns Jr, Retired Partner, Bear, Stearns & Co., Inc.
Kalevi Kurkij"arvi, PhD, Executive Chairman, Owner Innomedica Ltd.; Former Chairman & CEO, Co-Founder Bio Fund Management Oy
Miguel Madero, Fomento Direccion, Mexico
Rory B. Riggs, Managing Member, Balfour LLC; Former President and Director, Biomatrix, Inc.
Roberto Pedro Rosenkranz, PhD, MBA, Chairman and Chief Executive Officer, ROXRO PHARMA, Inc.; Director, Pherin Pharmaceuticals
Jorma Routti, PhD, Chairman of the Board of Directors, FibroGen Europe, Former Director General of the Directorate of Science, Research and Development of the European Commission
James A. Schoeneck, President and CEO, Depomed, Inc.
Julian N. Stern, Counsel to Goodwin Procter, LLP
Toshinari Tamura, PhD, Former Representative Director, Executive Vice President and Chief Science Officer of Astellas Pharma, Inc.

Technologies, Pharmaceuticals